Infection with an H2 recombinant herpes simplex virus vector results in expression of MHC class I antigens on the surfaces of human neuroblastoma cells in vitro and mouse sensory neurons in vivo
A. Abendroth et al., Infection with an H2 recombinant herpes simplex virus vector results in expression of MHC class I antigens on the surfaces of human neuroblastoma cells in vitro and mouse sensory neurons in vivo, J GEN VIROL, 81, 2000, pp. 2375-2383
The majority of neurons in herpes simplex virus (HSV)-infected murine senso
ry ganglia are transiently induced to express MHC-I antigens at the cell su
rface, whereas only a minority are themselves productively infected. The ai
m of the current work was to determine whether MHC-I antigens can be expres
sed on the surfaces of infected neurons in addition to their uninfected nei
ghbours. To address this aim a recombinant HSV type 1 strain, S-130, was us
ed to deliver a mouse H2K(d) gene, under control of the HCMV IE-1 promoter/
enhancer, into human neuroblastoma cells in vitro and mouse primary sensory
neurons in vivo. S-130 expressed H2K(d) antigens on the surfaces of IMR-32
cells, a human neuroblastoma cell line that expresses very low levels of M
HC-I constitutively. In K562 cells, which do not express MHC-I constitutive
ly, H2K(d) and beta(2)-microglobulin (beta(2)m) were shown to be co-express
ed at the cell surface following S-130 infection. This observation was take
n as evidence that class I heavy chain (alpha C) molecules encoded by the e
xpression cassette in the HSV genome were transported to the cell surface a
s stable complexes with beta(2)m Significantly, after introduction of S-130
into Rank skin, H2K(d) antigens were detected on the surfaces of primary s
ensory neurons in ganglia innervating the inoculation site, Our data show t
hat HSV-infected murine primary sensory neurons and human neuroblastoma cel
ls are capable of expressing cell-surface MHC-I molecules encoded by a tran
sgene, From this, we infer that up-regulation of alpha C expression is, in
principle, sufficient to overcome potential impediments to neuronal cell su
rface expression of MHC-I complexes.